5 Healthcare Stocks That Investors Should Be Eyeing in 2023

Healthcare is one of the industries that remain quite immune to recessions and other economic perils. Ergo, buying healthcare stock is certainly a wise choice for investors. However, you can’t just invest with vague assumptions. There’s a lot that keeps happening in the sector. Pharmacies, medical equipment-manufacturing firms, and health insurance companies take hits due to several reasons. Also, situations like pandemics change the dynamics of the market.

Based on the overarching analysis, experts talk about the best investment options every year in this industry. This year too, the keen market participants have a list to look forward to.

Healthcare Stocks That Could Be a Profitable Investment

Here are some stocks that are likely to bring profits into the portfolio. These companies are leading the markets with innovations and fair opportunities.

Eli Lilly & Co. (LLY) – NYSE

To begin with, LLY sells its products in over 120 countries. It has facilities in 18 countries and employs more than 34k people. Civil war veteran Eli Lilly established the company in 1876. Quinine was one of the first products that the company manufactured. With a total market cap of $441 Billion and a 10-year average annualized return of 27.9%, it promises great results for investors.

UnitedHealth Group Inc (UNH) – NYSE

By market capitalization, UNH is the biggest publicly-traded health insurance company. Founded in 1977, it operates throughout the US. The insurer has an impressive track record of distributing dividends. It offers an assortment of plans such as health saving accounts. A massive $439 Billion market cap and 23.7% of 10-year average annualized return make it a very reliable option for investors.

Johnson & Johnson (JNJ) – NYSE

Johnson & Johnson is one of the most popular pharmaceutical companies on earth. Founded in 1886, it manufactures a spectrum of products and has a presence in over 60 countries. With a market cap of $425 billion and a 10-year avg annualized return of 9.5%, it definitely is a valuable addition to the portfolio. Even with temporary downturns, it is worth long-term benefits.

Novo Nordisk A/S (NVO) – CPH

Novo has quite a few feathers in its cap. In 2012, it became the most sustainable company in the world. The company’s CEO Lars Fruergaard Jorgensen is a vice president of the European Federation of Pharmaceutical Industries and Associations (EFPIA). Boasting a market cap of $355 Billion and a 10-year average annualized return of 19.9%, it emerges as a precious addition to investors’ portfolios.

Merck & Co Inc (MRK) – NYSE

Established in 1668, it is the oldest pharmaceutical company on earth. Though it was founded in Germany, it is an American firm today. It made a vast array of products and spread enormously in its three centuries of existence. With a $289 Billion market cap and 13.5% of 10-year average annualized return, it’s one of the sought-after stocks in the healthcare industry.

Conclusion

As per the experts, investors may pocket good profit by investing in the aforementioned stocks. Nevertheless, every investor has to do their own research before putting their money intto any stock. But with some insights and recommendations, investments become easier for everyone. So, keep digging and be a shrewd investor.

Andrew is a blockchain developer who developed his interest in cryptocurrencies while his post-graduation. He is a keen observer of details and shares his passion for writing along with being a developer. His backend knowledge about blockchain helps him give a unique perspective to his writing